Investigational antibody-drug conjugates for hematological malignancies

Author： Polson Andrew G   Ho William Y   Ramakrishnan Vanitha  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.1, 2011-01, pp. : 75-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal antibody–drug conjugates

By Hamann Philip R  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 9, 2005-09 ,pp. : 1087-1103

Informa Healthcare

Access to resources Recommend Favorite

Investigational antibody drug conjugates for solid tumors

By Sapra Puja   Hooper Andrea T   O'Donnell Christopher J   Gerber Hans-Peter  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 8, 2011-08 ,pp. : 1131-1149

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in Antibody-Drug Conjugates for Breast Cancer Treatment

By  

Current Medicinal Chemistry, Vol. 24, Iss. 23, 2017-09 ,pp. : 2505-2527

Bentham Science Publishers

Access to resources Recommend Favorite

Marine Antibody–Drug Conjugates: Design Strategies and Research Progress

By Wang Yu-Jie   Li Yu-Yan   Liu Xiao-Yu   Lu Xiao-Ling   Cao Xin   Jiao Bing-Hua  

Marine Drugs, Vol. 15, Iss. 1, 2017-01 ,pp. : 18-18

MDPI

Access to resources Recommend Favorite

Antibody-Drug Conjugate Targets

By  

Current Cancer Drug Targets, Vol. 9, Iss. 8, 2009-12 ,pp. : 982-1004

Bentham Science Publishers

Access to resources Recommend Favorite